Research output: Contribution to journal › Article › peer-review
Delineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes. / Ivanisenko, Nikita V.; Buchbinder, Jörn H.; Espe, Johannes et al.
In: BMC Genomics, Vol. 20, No. Suppl 3, 293, 08.05.2019.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Delineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes
AU - Ivanisenko, Nikita V.
AU - Buchbinder, Jörn H.
AU - Espe, Johannes
AU - Richter, Max
AU - Bollmann, Miriam
AU - Hillert, Laura K.
AU - Ivanisenko, Vladimir A.
AU - Lavrik, Inna N.
PY - 2019/5/8
Y1 - 2019/5/8
N2 - Background: Structural homology modeling supported by bioinformatics analysis plays a key role in uncovering new molecular interactions within gene regulatory networks. Here, we have applied this powerful approach to analyze the molecular interactions orchestrating death receptor signaling networks. In particular, we focused on the molecular mechanisms of CD95-mediated NF-κB activation and the role of c-FLIP/NEMO interaction in the induction of this pathway. Results: To this end, we have created the homology model of the c-FLIP/NEMO complex using the reported structure of the v-FLIP/NEMO complex, and rationally designed peptides targeting this complex. The designed peptides were based on the NEMO structure. Strikingly, the experimental in vitro validation demonstrated that the best inhibitory effects on CD95-mediated NF-κB activation are exhibited by the NEMO-derived peptides with the substitution D242Y of NEMO. Furthermore, we have assumed that the c-FLIP/NEMO complex is recruited to the DED filaments formed upon CD95 activation and validated this assumption in silico. Further insight into the function of c-FLIP/NEMO complex was provided by the analysis of evolutionary conservation of interacting regions which demonstrated that this interaction is common in distinct mammalian species. Conclusions: Taken together, using a combination of bioinformatics and experimental approaches we obtained new insights into CD95-mediated NF-κB activation, providing manifold possibilities for targeting the death receptor network.
AB - Background: Structural homology modeling supported by bioinformatics analysis plays a key role in uncovering new molecular interactions within gene regulatory networks. Here, we have applied this powerful approach to analyze the molecular interactions orchestrating death receptor signaling networks. In particular, we focused on the molecular mechanisms of CD95-mediated NF-κB activation and the role of c-FLIP/NEMO interaction in the induction of this pathway. Results: To this end, we have created the homology model of the c-FLIP/NEMO complex using the reported structure of the v-FLIP/NEMO complex, and rationally designed peptides targeting this complex. The designed peptides were based on the NEMO structure. Strikingly, the experimental in vitro validation demonstrated that the best inhibitory effects on CD95-mediated NF-κB activation are exhibited by the NEMO-derived peptides with the substitution D242Y of NEMO. Furthermore, we have assumed that the c-FLIP/NEMO complex is recruited to the DED filaments formed upon CD95 activation and validated this assumption in silico. Further insight into the function of c-FLIP/NEMO complex was provided by the analysis of evolutionary conservation of interacting regions which demonstrated that this interaction is common in distinct mammalian species. Conclusions: Taken together, using a combination of bioinformatics and experimental approaches we obtained new insights into CD95-mediated NF-κB activation, providing manifold possibilities for targeting the death receptor network.
KW - C-FLIP
KW - Death receptor network
KW - Evolutionary conservation
KW - Homology modeling
KW - In silico
KW - NEMO
KW - NF-κB
KW - V-FLIP
KW - GAMMA
KW - APOPTOSIS
KW - KAPPA-B ACTIVATION
KW - COMPLEX
KW - PROTEIN
KW - NF-B
KW - DEATH
KW - MECHANISMS
KW - KINASE IKK
KW - REVEALS
UR - http://www.scopus.com/inward/record.url?scp=85065428080&partnerID=8YFLogxK
U2 - 10.1186/s12864-019-5539-y
DO - 10.1186/s12864-019-5539-y
M3 - Article
C2 - 31815628
AN - SCOPUS:85065428080
VL - 20
JO - BMC Genomics
JF - BMC Genomics
SN - 1471-2164
IS - Suppl 3
M1 - 293
ER -
ID: 20039484